Prices delayed by at least 15 minutes | Print


RaySearch Laboratories AB ser. B (RAY B)

Sell: 118.2 SEK|Buy: 119 SEK|Change: 1.80 (1.54%)

Open 

117 SEK


Previous close 

117 SEK


Trade high 

119 SEK


Volume 

23,344


Year high 

123.80 SEK


Year low 

55.60 SEK


Dividend yield 

-


Market capitalisation 

4.07 bn SEK


P/E ratio 

62.57


ISIN 

SE0000135485


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Performance 23/04/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
RaySearch Laboratories AB ser. B+ 1.54
More...

Company profile

RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare*oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.